Infinita
Infinita facilitates access to faster regulatory pathways for novel treatments
- Business Model
- B2B
- Website
- infinita.city
- Total Funding
- $3.0M
- Last Round
- $3.0M Seed
- Rounds
- 1
About
Infinita facilitates access to faster regulatory pathways for novel biotech treatments, coordinating between biotechs, clinics, and regulators under emerging frameworks such as Montana's Senate Bill 535. The company helps post-phase-1 (and select pre-phase-1) therapies reach patients through real-world evidence generation and structured treatment deployment and licensing, without itself developing or approving treatments.
Summary
Infinita is a Biotech company. It has raised $3.0M in total across 1 round. Investors include Winklevoss Capital and Boost VC.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Unknown
Investors
Similar Companies
Blockchain software company that developed the EOS.IO protocol, raising $4B+ in a record-breaking...
Regulated institutional-grade cryptocurrency exchange offering spot trading for Bitcoin, Ethereum...
Operator of renewable-powered data centers offering AI cloud, GPU compute, and Bitcoin mining inf...
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...